Rubric Capital Management LP's Form 4 filing
Heron Therapeutics, Inc. (HRTX) · filed Aug 12, 2025
- Accession no.
- 0000902664-25-003535
- Filed
- Aug 12, 2025, 6:00 PM ET
- Trade date
- Aug 8, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $3.58M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rubric Capital Management LPCIK 0001687509 | 10% Owner |
| Rosen David EfraimCIK 0001898677 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Common Stock, par value $0.01 per share ("Common Stock") | PPurchaseAcquired | +2,387,225 | $1.50 | +$3,580,837.5 | 29,100,728 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Convertible Senior Unsecured Promissory Notes ("Notes") | PPurchaseAcquired | – | $33,250,000.00 | – | – | Indirect | Price outlier |
| Aug 8, 2025 | Common Stock | PPurchaseAcquired | +946,100 | $15.00 | +$1,419,150 | 94,610 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.